Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Primary cervical screening with high risk human papillomavirus testing: observational study.

Rebolj M, Rimmer J, Denton K, Tidy J, Mathews C, Ellis K, Smith J, Evans C, Giles T, Frew V, Tyler X, Sargent A, Parker J, Holbrook M, Hunt K, Tidbury P, Levine T, Smith D, Patnick J, Stubbs R, Moss S, Kitchener H.

BMJ. 2019 Feb 6;364:l240. doi: 10.1136/bmj.l240.

2.

Prospective evaluation of p16/Ki-67 dual-stained cytology for managing women with abnormal Papanicolaou cytology: PALMS study results.

Bergeron C, Ikenberg H, Sideri M, Denton K, Bogers J, Schmidt D, Alameda F, Keller T, Rehm S, Ridder R; PALMS Study Group.

Cancer Cytopathol. 2015 Jun;123(6):373-81. doi: 10.1002/cncy.21542. Epub 2015 Apr 17.

3.

Screening for cervical cancer precursors with p16/Ki-67 dual-stained cytology: results of the PALMS study.

Ikenberg H, Bergeron C, Schmidt D, Griesser H, Alameda F, Angeloni C, Bogers J, Dachez R, Denton K, Hariri J, Keller T, von Knebel Doeberitz M, Neumann HH, Puig-Tintore LM, Sideri M, Rehm S, Ridder R; PALMS Study Group.

J Natl Cancer Inst. 2013 Oct 16;105(20):1550-7. doi: 10.1093/jnci/djt235. Epub 2013 Oct 4.

4.

Developing role of HPV in cervical cancer prevention.

Kitchener HC, Denton K, Soldan K, Crosbie EJ.

BMJ. 2013 Aug 7;347:f4781. doi: 10.1136/bmj.f4781. Review. No abstract available. Erratum in: BMJ. 2013;347:f5207.

PMID:
23926316
5.

p16/ki-67 dual-stain cytology in the triage of ASCUS and LSIL papanicolaou cytology: results from the European equivocal or mildly abnormal Papanicolaou cytology study.

Schmidt D, Bergeron C, Denton KJ, Ridder R; European CINtec Cytology Study Group.

Cancer Cytopathol. 2011 Jun 25;119(3):158-66. doi: 10.1002/cncy.20140. Epub 2011 Mar 25.

6.

The sensitivity and specificity of p16(INK4a) cytology vs HPV testing for detecting high-grade cervical disease in the triage of ASC-US and LSIL pap cytology results.

Denton KJ, Bergeron C, Klement P, Trunk MJ, Keller T, Ridder R; European CINtec Cytology Study Group.

Am J Clin Pathol. 2010 Jul;134(1):12-21. doi: 10.1309/AJCP3CD9YKYFJDQL.

PMID:
20551261
7.

The proposed BSCC terminology for abnormal cervical cytology.

Denton K.

Cytopathology. 2008 Dec;19(6):398-9. doi: 10.1111/j.1365-2303.2008.00624.x. No abstract available.

PMID:
19040547
8.

Ureteroscopic management of upper-tract urothelial cancer: an exciting nephron-sparing option or an unacceptable risk?

Painter DJ, Denton K, Timoney AG, Keeley FX.

J Endourol. 2008 Jun;22(6):1237-9. doi: 10.1089/end.2008.0187.

PMID:
18578656
9.

Correlation of upper-tract cytology, retrograde pyelography, ureteroscopic appearance, and ureteroscopic biopsy with histologic examination of upper-tract transitional cell carcinoma.

Williams SK, Denton KJ, Minervini A, Oxley J, Khastigir J, Timoney AG, Keeley FX Jr.

J Endourol. 2008 Jan;22(1):71-6. doi: 10.1089/end.2007.9853.

PMID:
18315477
10.

Liquid based cytology in cervical cancer screening.

Denton KJ.

BMJ. 2007 Jul 7;335(7609):1-2. No abstract available.

11.

The modern management of upper urinary tract urothelial cancer: tumour diagnosis, grading and staging.

Painter DJ, Timoney AG, Denton K, Alken P, Keeley FX Jr.

BJU Int. 2007 May;99(5):973-7. Review. No abstract available.

Supplemental Content

Loading ...
Support Center